A detailed history of Bessemer Group Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Bessemer Group Inc holds 11,619 shares of NEO stock, worth $190,435. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,619
Previous 12,601 7.79%
Holding current value
$190,435
Previous $174,000 1.15%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$13.4 - $17.73 $13,158 - $17,410
-982 Reduced 7.79%
11,619 $172,000
Q1 2024

May 13, 2024

SELL
$14.06 - $16.79 $112,480 - $134,320
-8,000 Reduced 38.83%
12,601 $199,000
Q4 2023

Feb 09, 2024

BUY
$11.67 - $20.73 $20,422 - $36,277
1,750 Added 9.28%
20,601 $333,000
Q3 2023

Nov 13, 2023

BUY
$12.15 - $17.85 $34,566 - $50,783
2,845 Added 17.77%
18,851 $231,000
Q2 2023

Aug 10, 2023

BUY
$14.1 - $19.83 $1,480 - $2,082
105 Added 0.66%
16,006 $258,000
Q1 2023

May 10, 2023

BUY
$9.09 - $19.45 $71,820 - $153,674
7,901 Added 98.76%
15,901 $277,000
Q3 2022

Nov 09, 2022

BUY
$7.86 - $12.91 $62,880 - $103,280
8,000 New
8,000 $69,000
Q2 2022

Aug 10, 2022

SELL
$7.06 - $13.97 $713 - $1,410
-101 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$12.15 - $35.28 $1,117 - $3,245
-92 Reduced 47.67%
101 $1,000
Q4 2021

Jan 27, 2022

BUY
$30.49 - $48.49 $2,805 - $4,461
92 Added 91.09%
193 $7,000
Q1 2021

May 13, 2021

SELL
$41.56 - $59.88 $6,608 - $9,520
-159 Reduced 61.15%
101 $4,000
Q4 2020

Feb 09, 2021

BUY
$36.08 - $56.47 $9,380 - $14,682
260 New
260 $14,000
Q3 2019

Nov 07, 2019

SELL
$19.12 - $26.24 $0 - $0
0 Closed
0 $0
Q2 2019

Jul 19, 2019

BUY
$19.57 - $24.1 $0 - $0
0 New
0 $0
Q1 2019

May 13, 2019

SELL
$12.14 - $20.46 $75,268 - $126,852
-6,200 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$11.24 - $18.5 $69,688 - $114,700
6,200 New
6,200 $78,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.06B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.